share_log

Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital

Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital

Tonix Pharmicals 已在马萨诸塞州综合医院招收了第一位参与者 TNX-1900(鼻内增强催产素)治疗儿科肥胖症的 “POWER” 第二阶段 “POWER” 研究
Benzinga ·  2023/07/10 07:06

Tonix Pharmaceuticals Has Enrolled The First Participant In Phase 2 'POWER' Study Of TNX-1900 (Intranasal Potentiated Oxytocin) For Pediatric Obesity At The Massachusetts General Hospital

Tonix Pharmicals 已在马萨诸塞州综合医院招收了第一位参与者 TNX-1900(鼻内增强催产素)治疗儿科肥胖症的 “POWER” 第二阶段 “POWER” 研究

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发